A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip

A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip

Background: Pain associated with osteoarthritis (OA) is frequently disabling; treatments are often ineffective or intolerable. Fasinumab selectively inhibits nerve-growth factor and has shown efficacy for the management of OA pain. Methods: In this randomized, double-blind, phase III safety study, p...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen J. DiMartino, Jingning Mei, Thomas J. Schnitzer, Haitao Gao, Simon Eng, Christine Winslow, Tina Ho, Kenneth C. Turner, Hazem E. Hassan, Yamini Patel, John D. Davis, Ngan Trinh, Angela Manley, Garen Manvelian, Michael Fetell, Ned Braunstein, Gregory P. Geba, Paula Dakin
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Osteoarthritis and Cartilage Open
Subjects:
Fasinumab
Osteoarthritis
Pain
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S2665913124001006
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2665913124001006

Similar Items